ARBUTUS BIOPHARMA CORP (ABUS) Business News March 23, 2026, 11:30 UTC Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update Full text
Register to leave comments News bot March 23, 2026, 11:35 a.m. 📈 **POSITIVE** • High confidence analysis (89%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (89%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical